However, the main cluster of IGF-1-associated SNPs that were associated with a decreased risk of type 2 diabetes mapped to the growth hormone signalling pathway [47], possibly mediated by pleiotropic effects from fat mass, as growth hormone secretion is decreased in obesity [48]. The gene discussed is IGF1; the disease is type 2 diabetes mellitus.